Clinical Trial Update: Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 2L NRL994 with sodium phosphate (NaP) bowel cleansing preparation for colonoscopy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Neoplasms

Drugs mentioned

• NRL994
• NaP Preparation (sodium phosphate bowel cleansing preparation)

Snippet

Sponsor: Norgine | Conditions: Colonoscopy | Phase 3 | Status: COMPLETED